QQ客服 官方微博 反馈留言

	Anticancer activity of 1,25-(OH)2D3 against human breast cancer cell lines by targeting Ras/MEK/ERK pathway.
	Zheng, Wei*; Cao, Lin; Ouyang, Linna; Zhang, Qian; Duan, Bofeng; Zhou, Wei; Chen, Shan; Peng, Wei; Xie, Yi; Fan, Qing
刊名	OncoTargets and Therapy
	2019
卷号	12页码:721-732
关键词	25-(OH)2D3 ER-negative breast cancer cell apoptosis cell proliferation
ISSN号	1178-6930
DOI	10.2147/OTT.S190432
URL标识	查看原文
WOS记录号	WOS:000456671300001
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5681077
专题	南华大学
作者单位	1.[Ouyang, Linna 2.Zheng, Wei 3.Peng, Wei 4.Xie, Yi 5.Duan, Bofeng] Third Peoples Hosp Shenzhen, Dept Thyroid & Breast Surg, 29 Bulan Rd, Shenzhen 518112, Guangdong, Peoples R China.
推荐引用方式 GB/T 7714	Zheng, Wei*,Cao, Lin,Ouyang, Linna,et al. Anticancer activity of 1,25-(OH)2D3 against human breast cancer cell lines by targeting Ras/MEK/ERK pathway.[J]. OncoTargets and Therapy,2019,12:721-732.
APA	Zheng, Wei*.,Cao, Lin.,Ouyang, Linna.,Zhang, Qian.,Duan, Bofeng.,...&Gong, Daoxing.(2019).Anticancer activity of 1,25-(OH)2D3 against human breast cancer cell lines by targeting Ras/MEK/ERK pathway..OncoTargets and Therapy,12,721-732.
MLA	Zheng, Wei*,et al."Anticancer activity of 1,25-(OH)2D3 against human breast cancer cell lines by targeting Ras/MEK/ERK pathway.".OncoTargets and Therapy 12(2019):721-732.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。